PHC Holdings Corporation (TYO:6523)
Japan · Delayed Price · Currency is JPY | Market Cap | 141.06B +4.0% |
| Revenue (ttm) | 363.93B -0.1% |
| Net Income | 3.54B -40.0% |
| EPS | 27.82 -40.4% |
| Shares Out | 126.51M |
| PE Ratio | 40.08 |
| Forward PE | 11.15 |
| Dividend | 42.00 (3.77%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 383,700 |
| Average Volume | 277,560 |
| Open | 1,120.00 |
| Previous Close | 1,114.00 |
| Day's Range | 1,105.00 - 1,130.00 |
| 52-Week Range | 856.00 - 1,189.00 |
| Beta | 0.69 |
| RSI | 58.08 |
| Earnings Date | May 13, 2026 |
About PHC Holdings
PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management; Healthcare Solutions; and Diagnostic and Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and histology consumables; cell growth and preservation, such as CFC-free ultra-low temperature freezers, CO2 incubators, and live cell metabolic analyzer an... [Read more]
Financial Performance
Financial StatementsNews
Epredia and Mindpeak Announce EU Distribution Agreement for AI-Powered Image Recognition in Cancer Diagnostics
RUNCORN, United Kingdom--(BUSINESS WIRE)-- #AI--Epredia, a global leader in precision cancer diagnostics and a subsidiary of PHC Holdings Corporation (TSE: 6523), and Mindpeak, a leading provider of a...